Novo Nordisk A/S (NOVOBN)
BMV
Real-time Data
02:30 PM
Day's Range
800.0052 wk Range
630.00Overview - NOVOBN - Novo Nordisk A/S
Key Statistics
Valuation
Enterprise Value
9.61T
P/E (Trailing)
‪11.49‬
PEG Ratio
‪-0.56‬
Price / Sales (TTM)
‪10.73‬
Price / Book
‪6.06‬
EV / EBITDA
‪20.94‬
Profitability
Gross Margin
‪78.21%‬
Profit Margin
‪35.34%‬
Operating Margin
‪42.54%‬
Return on Assets
‪18.72%‬
Return on Equity
‪59.81%‬
Ownership
Shares Outstanding
4.42B
Float
3.17B
Held by Insiders
‪5.28%‬
Held by Institutions
‪33.32%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪836.05‬
200-Day Avg
‪842.31‬
Dividends
Payout Ratio
‪44.57%‬
Frequency
Semi-Annual
Market Cap - NOVOBN - Novo Nordisk A/S
Peers - NOVOBN - Novo Nordisk A/S
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BMV.
Profile Summary - NOVOBN - Novo Nordisk A/S
About
Novo Nordisk A/S is a global pharmaceutical company specializing in research, development, and manufacturing of treatments for serious chronic diseases. Founded through the 1989 merger of Danish insulin pioneers Nordisk Insulaboratorium and Novo Terapeutisk Laboratorium, it traces its roots to 1923 when commercial…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
